# Several drugmakers have been developing lower-cost versions of Novo Nordisk's diabetes drug Ozempic.

*biotech · news · 2026-04-28 · Reuters*

## Key points

- India was the first major market to launch copycat semaglutide after patent expiries in March.
- Novo Nordisk cut Ozempic and Wegovy prices in India following the entry of generics.
- Health Canada is reviewing eight applications for generic semaglutide from different companies.
- Canadian generic medications are typically 45% to 90% cheaper than brand-name versions.

**Companies:** Novo Nordisk, Dr Reddy's
**Countries:** India, Canada, United States

[Read the full story on Reuters](https://www.reuters.com/legal/litigation/health-canada-approves-first-generic-version-novo-nordisks-ozempic-2026-04-28/)

---

Canonical: https://newsio.io/n/6bd02fcf-8530-4844-945b-9d0c3ee08658/several-drugmakers-have-been-developing-lower-cost-versions-of-novo-nordisks-dia
Summarized by Newsio from Reuters. https://newsio.io/how-it-works